Chief Executive Officer
Employed at Rhenman & Partners since: 2023
Teresa has law degrees from Humboldt Universität zu Berlin and Stockholm University, a master’s degree in international Commercial Arbitration from Stockholm University, as well as a Diploma in English Legal Studies from Kings College, London.
Founding Partner / Chief Investment Officer
Employed at Rhenman & Partners since: 2008
Over 25 years of experience in portfolio management.
Education: Biochemist, Royal Institute of Technology, B.Sc., Stockholm School of Economics.
Chief Operating Officer
Employed at Rhenman & Partners since 2023.
20 years of experience in the financial and fund sector. Education: B.Sc. in Economics, Jönköping International Business School.
Employed at Rhenman & Partners since: 2017.
Education: Business Administration, Finance, B.Sc., Stockholm Business School.
Employed at Rhenman & Partners since: 2020.
Education: B.Sc. Business & Economics, Stockholm School of Economics.
Employed at Rhenman & Partners since: 2023.
15 years of experience in medical positions within the life science industry. Education: M.Sc. Biomedicine and a PhD, Karolinska Insitute.
Affiliated to Rhenman & Partners since: 2012.
Over 30 years of experience in the stock market.
Education: LL.B., Master of Laws, University of Stockholm.
Erica von Bahr
Employed at Rhenman & Partners since: 2022.
10 years of experience in wealth management. Education: M.Sc. in Business Administration, Finance, Linköping University
Employed at Rhenman & Partners since: 2021.
15 years of experience from marketing and communications roles within the financial sector. Education: M.Sc. in Business and Economics, Karlstad University.
Employed at Rhenman & Partners since: 2013.
Board of Directors
Professor Hans Wigzell
Chairman of the Board
Professor emeritus of Immunology, Karolinska Institutet. Former president of Karolinska Institutet, head of the Infectious Disease Institute, the State Bacteriological Laboratory and chair of Karolinska Institutet’s Nobel Committee. Member of the Royal Academy of Sciences and the Royal Swedish Academy of Sciences IVA. Total number of active board assignments: 4.
Birgitta Stymne Göransson
M.Sc. in Chemistry/Biotechnology, Royal Institute of Technology (KTH), and MBA Harvard Business School. Board member Elekta AB, Pandora A/S, BCB Medical Oy, Bure Equity AB and Chairman of the Boards of Industrifonden. Previously CEO of Memira Group, COO at Telefos, McKinsey Associate and Product manager at Gambro. Total number of active board assignments: 6
Degree of Master of Science in Business and Economics, Uppsala Universitet
Chairman of the bord in AMF Tjänstepension and Nyvik Group
Board member in Höganäs AB, IPCO AB, The Stockholm Chamber of Commerce (Vice Chairman), Rederi AB Gotland and tbd30
Previously CEO of FAM AB, CFO Alfred Berg and CFO Investor AB.
Previously Board member at Nasdaq Group Inc, SKF, Grand Hôtel och FAM.
Total number of active board assignments: 8.
Lawyer (jurist), LL.M in Law, Uppsala University Previously: Associate Judge (hovrättsassessor) Svea Court of Appeal, Legal Counsel Skandia Insurance Company, Deputy General Counsel and deputy head of the Legal & Security Deparment of Sweden Post, General Counsel Postgirot Bank AB, Group General Counsel Carnegie Investment Bank, Lawyer (Advokat)
Active board assignments: The Hans Wigzell Research Foundation, Hoflund Juridik AB
Total number of active board assignments: 3.
Biochemist, Royal Institute of Technology and M.Sc., School of Business. Founder and Managing Director, Rhenman & Partners. Former Founder & CIO, Carnegie Healthcare Funds, Carnegie Investment Bank. Managing Director, Portfolio Manager, SG Cowen, Boston. Portfolio manager, SEB Pharmaceutical Fund. Head of Analysis, Hagströmer & Qviberg. Total number of active board assignments: 2.